FluoroPharma CEO Thijs Spoor to Be Interviewed Live Today on Clear Channel Business Talk Radio
April 02 2014 - 8:14AM
Marketwired
FluoroPharma CEO Thijs Spoor to Be Interviewed Live Today on Clear
Channel Business Talk Radio
Interview Scheduled at 2:05pm EDT / 12:05 pm MDT / 11:05am PDT
on The Traders Network Radio Show, Hosted by Michael Yorba
MONTCLAIR, NJ--(Marketwired - Apr 2, 2014) - FluoroPharma
Medical, Inc. (OTCQB: FPMI) ("FluoroPharma"), a company
specializing in the development of novel diagnostic imaging
products that utilize positron emission tomography (PET) technology
for the detection and assessment of disease before clinical
manifestation, announced today its CEO, Thijs Spoor, will be
interviewed live today by host Michael Yorba on Clear Channel
Business Talk Radio's The Traders Network Show. Any
interested parties may tune in and listen live via Clear Channel's
nationally syndicated iHeart Radio stream.
The live interview details are as follows:
Date: Wed, April 2, 2014 Start Time: 11:05am PDT | 12:05pm
MDT | 2:05pm EDT (U.S.) Network: Clear Channel Station: DFW 1190AM
KFXR Show: The Traders Network Host: Michael Yorba Live iHeart
Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
About Clear Channel: Clear Channel's Media and Entertainment
division has the largest reach of any radio or television outlet in
America with 243 million monthly listeners. It serves 150 cities
through 850 owned radio stations in the U.S., as well as more than
140 stations in New Zealand and Australia.
www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and
featured host on Clear Channel. For the past six years he has
produced and hosted The Traders Network Show broadcasted live daily
on Clear Channel DFW 1190AM KFXR from 1pm - 3pm CT,
Monday-Friday.
Michael Yorba interviews the front-page Titans about the latest
in capital markets, CEO milestones, trading tools, real estate
acquisitions and market trends. Learn how the experts use risk
management techniques to build fully diversified portfolios and
what it takes to put up big board earnings. It's a fast moving,
high-energy show that presents stocks, commodities, bonds, forex,
derivatives, real estate, political trends, technology trends,
crowd funding and impact investment insights in a new light and
keeps audience asking for more... shift your thinking and join us
as we deliver "tomorrow's ideas today" on Clear Channel's The
Traders Network Show.
About FluoroPharma Medical:
FluoroPharma is a biopharmaceutical company engaged in the
discovery and development of proprietary PET imaging products to
evaluate cardiac disease at the cellular and molecular levels. The
company has licensed technology from the Massachusetts General
Hospital in Boston.
The company's goal is to enable personalized medicine through
precision diagnostics that will help the medical community diagnose
disease more accurately at the earliest stages, leading to more
effective treatment, management and better patient outcomes.
FluoroPharma's initial focus is the development of breakthrough
PET imaging agents and is advancing two products in clinical trials
for assessment of acute and chronic forms of coronary artery
disease. These first in class agents have been designed to rapidly
target myocardial cells. Other products in development include
agents for detection of inflamed atherosclerotic plaque in
peripheral arteries, agents with the potential to image brain
tissue affected by Alzheimer's disease and agents that could
potentially be used for imaging specific cancers.
In addition to the United States, Europe and China, patents
related to FluoroPharma's portfolio of imaging compounds have been
issued in Japan, Canada, Australia, Finland, Portugal, Ireland and
Mexico.
For more information on the company, please visit:
www.fluoropharma.com
A www.1800PublicRelations.com PR
Event
Contacts: Investor Relations: The Del Mar Consulting Group, Inc.
Robert B. Prag President Phone: 858-361-1786
bprag@delmarconsulting.com Richard Moyer Cameron Associates, Inc.
Richard@cameronassoc.com Phone: 212-554-5466 Press/Media Contact:
Matthew Bird President MUNCmedia Public Relations Phone:
917-409-8211 matt.bird@muncmedia.com www.muncmedia.com Carol
Perlman FluoroPharma Medical, Inc. cperlman@fluoropharma.com Phone:
917-592-9260
FluoroPharma Medical (CE) (USOTC:FPMI)
Historical Stock Chart
From Jul 2024 to Aug 2024
FluoroPharma Medical (CE) (USOTC:FPMI)
Historical Stock Chart
From Aug 2023 to Aug 2024